EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Clinical trial NCT03002844 · UNKNOWN

Trial details

NCT number: NCT03002844
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nonsmall Cell Lung Cancer EGFR Gene Mutation

Start date: 2016-12-01
Primary completion: 2017-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.